3WG-11589-00136

4 vaccinations 7 coded responses 28 check-ins 6 free-text entries 1 call case

Sex: Female
Age at first dose: 31-35
ZIP prefix: 198 / DE
Registered: 2021-03-26

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1795003 (opens in a new window)	high	9 / 11	7	3 of 15 VAERS symptoms	same dose (2)	DE matches	2021-04-16 / 2021-09-07 / 2021-10-18 received the same day as the last call	case 1096572

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Registered in v-safe
2021-03-26
Dose 1 — Pfizer-BioNTech
2021-03-26
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-04-04
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-16
Dose 2 — Pfizer-BioNTech
2021-04-16
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Nausea

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-07-16
Survey response — 3 months, dose 2
MedDRA: Headache, Pregnancy — Feeling: Good

Free text: Frequent headaches but may be associated with pregnancy.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-10-15
Survey response — 6 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Pregnant, Covid

MedDRA releases: 2024-11 · check-in free text available
2021-10-15
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-10-18
Call successful
Completed over the phone
2022-01-13
Dose 3 — Pfizer-BioNTech
2022-01-13
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site

Adult check-in
2022-01-15
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Joint pains, Rash, not including the immediate area around the injection site

Adult check-in
2022-01-16
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Joint pains, Rash, not including the immediate area around the injection site

Adult check-in
2022-01-17
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Joint pains

Adult check-in
2022-01-22
Survey response — day 7, dose 3
MedDRA: Respiratory tract congestion — Feeling: Fair · Headache

Free text: Stuffiness

MedDRA releases: 2024-11 · check-in free text available
2022-01-27
Survey response — day 14, dose 3
MedDRA: Rash, Rash erythematous — Feeling: Fair

Free text: Lacey red rash inside and around of both elbows has reappeared. Initially, developed this rash after receiving the Pfizer covid booster shot which lasted for a couple days and then disappeared. Only to come back today.

MedDRA releases: 2024-11 · check-in free text available
2022-02-03
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-02-12
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-02-17
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2022-02-28
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-12-02
Dose 4 — Pfizer-BioNTech
2022-12-06
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-12-11
Health check-in — day 7, dose 4
Feeling: Fair · Fatigue or tiredness

Adult check-in
2022-12-18
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-12-23
Survey response — day 21, dose 4
MedDRA: Cough, Throat tightness — Feeling: Fair

Free text: Tightness in throat and mild cough

MedDRA releases: 2024-11 · check-in free text available
2022-12-31
Survey response — day 28, dose 4
MedDRA: Heavy menstrual bleeding, Nasopharyngitis — Feeling: Fair

Free text: Cold symptoms; heavier period than usual

MedDRA releases: 2024-11 · check-in free text available
2023-01-14
Survey response — day 42, dose 4
MedDRA: Nasopharyngitis, Rash — Feeling: Fair

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-16	Pfizer-BioNTech
3	2022-01-13	Pfizer-BioNTech	No
4	2022-12-02	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-10-15	Successful 2021-10-18	Completed over the phone

Free text

Release 9 — 3 months, dose 2

2021-07-16

Symptoms: Frequent headaches but may be associated with pregnancy.

Release 10 — 6 months, dose 2

2021-10-15

Symptoms: Pregnant, Covid

Release 11 — day 7, dose 3

2022-01-22

Systemic reaction (other): Stuffiness

Release 11 — day 14, dose 3

2022-01-27

Symptoms: Lacey red rash inside and around of both elbows has reappeared. Initially, developed this rash after receiving the Pfizer covid booster shot which lasted for a couple days and then disappeared. Only to come back today.

Release 12 — day 21, dose 4

2022-12-23

Symptoms: Tightness in throat and mild cough

Release 12 — day 28, dose 4

2022-12-31

Symptoms: Cold symptoms; heavier period than usual

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Headache	✓	·	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pregnancy	✓	·	✓
SD	Rash	·	·	✓
SD	Rash erythematous	·	·	✓
SD	Throat tightness	·	·	✓
SRO	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release